Argus Reaffirms "Hold" Rating for Bath & Body Works (NYSE:BBWI)

Key Points

• Argus reaffirmed its “Hold” rating on Bath & Body Works, aligning with the broader analyst consensus. Fifteen analysts rate the stock Hold, compared with four Buys and one Sell, while the average price target is $22.13.
• BBWI shares opened at $16.70, down 6.7%, with a 12-month range of $14.27 to $27.40 and a market capitalization of approximately $3.37 billion.
• The company exceeded quarterly earnings expectations, reporting $0.62 EPS versus the $0.24 consensus and $1.51 billion in revenue, though revenue declined 2.3% year over year. Institutional investors own approximately 95.14% of the company.

Bath & Body Works (NYSE:BBWI - Get Free Report)'s stock had its "hold" rating reissued by equities research analysts at Argus in a note issued to investors on Wednesday, Benzinga reports.

Several other equities research analysts also recently commented on the company. Raymond James Financial reissued a "market perform" rating on shares of Bath & Body Works in a report on Wednesday, May 27th. Weiss Ratings upgraded shares of Bath & Body Works from a "sell (d+)" rating to a "hold (c-)" rating in a research report on Thursday, July 9th. Robert W. Baird cut their target price on shares of Bath & Body Works from $25.00 to $23.00 and set a "neutral" rating for the company in a research report on Thursday, August 27th. BMO Capital Markets started coverage on Bath & Body Works in a report on Tuesday, September 8th. They issued a "market perform" rating and a $20.00 target price on the stock. Finally, Telsey Advisory Group cut their price target on Bath & Body Works from $25.00 to $22.00 and set a "market perform" rating for the company in a research note on Thursday, May 28th. Four research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat, Bath & Body Works presently has a consensus rating of "Hold" and an average price target of $22.13.

Bath & Body Works Trading Down 6.7%

Shares of BBWI stock opened at $16.70 on Wednesday. Bath & Body Works has a 12 month low of $14.27 and a 12 month high of $27.40. The stock has a market cap of $3.37 billion, a PE ratio of 4.35, a price-to-earnings-growth ratio of 1.84 and a beta of 1.38. The company's fifty day moving average price is $19.48 and its 200-day moving average price is $19.53.

Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its quarterly earnings results on Wednesday, August 26th. The company reported $0.62 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.24 by $0.38. Bath & Body Works had a net margin of 10.83% and a negative return on equity of 53.48%. The company had revenue of $1.51 billion during the quarter, compared to analysts' expectations of $1.50 billion. During the same period last year, the company posted $0.30 EPS. Bath & Body Works's revenue was down 2.3% on a year-over-year basis. Bath & Body Works has set its Q3 2026 guidance at 0.070-0.120 EPS and its FY 2026 guidance at 2.600-2.800 EPS. On average, sell-side analysts forecast that Bath & Body Works will post 2.73 earnings per share for the current fiscal year.

Institutional Trading of Bath & Body Works

Institutional investors have recently made changes to their positions in the business. Elevation Wealth Partners LLC increased its position in shares of Bath & Body Works by 5,278.8% during the second quarter. Elevation Wealth Partners LLC now owns 1,775 shares of the company's stock worth $41,000 after acquiring an additional 1,742 shares during the period. Eurizon Capital SGR S.p.A. purchased a new stake in shares of Bath & Body Works during the 4th quarter valued at $50,000. MidFirst Bank acquired a new stake in shares of Bath & Body Works in the 4th quarter worth $51,000. Parallel Advisors LLC grew its stake in Bath & Body Works by 35.5% during the 1st quarter. Parallel Advisors LLC now owns 2,570 shares of the company's stock worth $48,000 after buying an additional 673 shares during the last quarter. Finally, Meeder Asset Management Inc. purchased a new position in Bath & Body Works during the 2nd quarter worth $66,000. Hedge funds and other institutional investors own 95.14% of the company's stock.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailer focused on personal care and home-fragrance products. Its offerings include body lotions and creams, shower gels, fragrance mists, hand soaps and sanitizers, candles, home fragrances, and related seasonal merchandise. The company markets products under the Bath & Body Works and White Barn names.

The company sells its products through a network of company-operated stores, its websites, and other direct channels. Its retail operations primarily serve customers in the United States and Canada, while international markets are reached through franchised, licensed, and other distribution arrangements.

Bath & Body Works traces its origins to 1990 and was formerly part of L Brands, Inc It became an independent publicly traded company in 2021 following the separation of L Brands' Victoria's Secret business.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.